?? Exciting News! ?? Nature Methods has crowned Spatial Proteomics as the Method of the Year! At Sirona Dx, we’re proud to have been at the forefront of this revolutionary field for over six years. In collaboration with leading platform innovators like Standard BioTools, Akoya, Lunaphore, Nanostring, and most recently, Hamamatsu, we've continually pushed the boundaries of spatial biology. From platform selection to assay development and advanced analysis, our dedicated team remains steadfast in delivering cutting-edge solutions and services for our clients. Here’s to a future of innovation and discovery! ?? Read the full article here: https://lnkd.in/epNmXHh9
关于我们
Sirona Dx is a technical CRO, providing advanced, high complexity, single cell, multi omics services to accelerate the pace of immunotherapy and targeted therapy development. In contrast to most CROs, we embrace leading edge technologies at an earlier stage, often assisting life science companies with product development. Bridging the silos between tools developers and biopharma means our clients access enabling technologies and expertise sooner and within a CLIA accredited, GCLP laboratory that supports pharma regulatory requirements. Our team can assist with platform selection and with the design, optimization and validation of complex multi-analyte assays. Harness breakthrough technologies to profile and integrate biology with single-cell resolution including tissue spatial context to reveal the next generation of precision biomarker signatures to accelerate therapies towards regulatory approval. Recognized as the original pioneers of spatial biology we launched the first spatial-omics CRO service in 2018 utilizing IMC technology developed by Fluidigm. Today our technology agnostic, spatial biology suite includes all of the leading multiplexed imaging platforms. Our team can develop panels of up to 40 markers to reveal the complex interplay between the immune system and the tumor/tissue microenvironment. We leverage CyTOF technology from Fluidigm to perform ultradeep immune profiling of whole blood and PBMCs with highly multiplexed assays of 40+ markers. High performance RNA extraction methodologies coupled with a comprehensive menu of high parameter IO expression profiling assays supports exploration of complex tumor immunobiology from challenging sample types. From exploratory testing and biomarker development through to clinical trials support, we partner with you every step of the way. Contact us with your specific requirements and our team will guide you to the optimal assays and platforms to support your study.
- 网站
-
https://www.sironadx.com
Sirona Dx的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Portland，Oregon
- 类型
- 私人持股
- 创立
- 2016
- 领域
- High Complexity Genomics、High Complexity Proteomics、IO Expression profiling、Immunophenotyping、Imaging Mass Cytometry、Mass Cytometry、Flow Cytometry、Assay Development、Clinical Trial Support、CyTOF、multiplexed IHC、Single cell、RNA extraction、Spatial Biology、Spatialomics、Single cell proteomics、Single cell genomics、CODEX、IHC和Bioinformatics
地点
-
主要
获取路线
4640 SW Macadam Ave
US，Oregon，Portland
Sirona Dx员工
动态
-
We are thrilled to welcome Dr Carlo Bifulco, MD to our Scientific Advisory Board. Dr. Bifulco is a board-certified Surgical Pathologist with specialized training in Molecular Genetic Pathology and Hematopathology. He is the Chief Medical Officer at Providence Genomics and leads the Translational Molecular Pathology division at the Earle A. Chiles Research Institute, part of the Providence Cancer Institute in Portland, Oregon. Before his current role, Dr. Bifulco was a faculty member at Yale University's Pathology department and completed fellowships at Memorial Sloan Kettering Cancer Center and Yale. His research focuses on integrating personalized medicine, spatial biology, and AI. Dr Bifulco will provide strategic guidance and consultation to the Sirona Dx team as we continue our mission to provide transformational spatial biology and single cell services and products to accelerate the development of next generation therapies. #spatialbiology #digitalpathology #CRO #precisionmedicine #immunotherapy #JEDI #AI Carlo Bifulco
-
-
Sirona Dx and Nanostring have partnered to provide a grant award for a 2 slide CosMx Human 6K study Here's the scoop: ? Enables a 2-Slide CosMx Human 6K Discovery Panel Project ?Includes reagents ?Includes project planning and data analysis consultation ?Study will be run at Sirona Dx’s GCLP and CLIA accredited facility in Portland, OR Click below to apply: https://lnkd.in/gGjXiUwj
-
Join us today for a live webinar describing our experience with the CosMx SMI platform including the new CosMx? Human 6K Discovery Panel. This event will feature presentations from our scientific, bioinformatics and regulatory leads and includes the opportunity to win a grant award for a CosMx? Human 6K study. Sirona Dx was the first CRO to install and run the CosMx? Spatial Molecular Imager and we have been running client samples since mid 2023. Register at the link below: https://lnkd.in/g5D3dmCk #spatialbiology #nanostring #CosMx #CRO #biopharma #spatialmultiomics #singlecell #biomarkers
-
Sirona Dx转发了
PredxBio, a leader in spatially intelligent biology, and Sirona Dx, a leader in single cell multi-omics, analytical services, have announced today a strategic partnership aimed at reshaping the landscape of drug discovery and development. This collaboration marks a pivotal moment in the industry, leveraging Explainable AI-Driven Spatial Biology with a groundbreaking new platform #SpaceIQ? to unlock the potential of genomic, proteomic, and transcriptomic data through advanced spatial analytics. Read the press release here: https://lnkd.in/g5DeBQYY #SpaceIQ #PredxBio #SironaDx #ExplainableAI #SpatialBiology #SpatialMultiOmics #SpatialOmics #SpatialComputing #UnbiasedAnalytics #AI #Cancer #Innovation #CancerResearch #CancerCare Dusty Majumdar, PhD, S. Chakra Chennubhotla, Andrew Brown, Craig Cinquina, Akif Burak Tosun, Filippo Pullara, Brian Falkenstein, Meredith Manuel, John F. Beeler, PhD, Alex Tamburino, Agnes Haggerty, PhD, Angela Vasaturo, Ata Tuna CIFTLIK, Chung-Wein Lee, Gulpreet Kaur, Ph.D., Peter Erin, CFA, Todd Parker, Ben Goldberg, Chris Leidel, Buer Song, MD. PhD., Katie Maloney, Imogen Fitt, Alexandra Bream
-